MedTech Europe engages with global agencies, decision-makers and stakeholders on key international issues facing medical technology companies.
Medical technologies are used around the world to save and improve lives, to inform citizens on the state of their health and to guide healthcare delivery. While Europe remains a centre of innovation where medical technologies are often developed and first deployed, thousands of medical technology products are exported from Europe every year, helping to improve global health outcomes. MedTech Europe helps to ensure that these products compete freely and fairly in international markets.
Our international affairs team ensures that Europe’s innovative medical technology industry is represented at a global level. Key areas of activity include trade, global health policy and engagement with international partners.
International regulators, standards and policy-making bodies play a central role in shaping global healthcare. MedTech Europe engages with stakeholders and decision-makers around the world on issues of common interest.
Medical technology companies operate in diverse global markets. Specific insights on regulatory, ethical and procurement environment are essential to expanding to new markets.
Global Health Policy
Through our advocacy efforts, technical expertise, and holistic approach, MedTech Europe actively engages on many international issues of relevance for the medical technology sector.
Trade & Customs
As a global industry, trade negotiations and customs rules play an important role in bringing medical technologies to customers and patients around the world. MedTech Europe is actively engaged in trade and customs issues at European and international level.
Brexit is a critical topic for the medical technology industry which has developed highly complex ties between the United Kingdom (UK) and the rest of the EU. Medical technologies are often moved between different EU countries during their production lifecycle and their clinical use. Crucially, up to 30% of our industry’s products have been authorised via UK Notified Bodies (CE marking) and could lose such authorisation overnight in the case of a “cliff edge” Brexit. MedTech Europe is tracking developments closely and has produced a position paper and other relevant documents to help medical technology companies to navigate Brexit.
IMDRF meeting in Berlin – Save the date: 25-26 September 2023
Posted on 04.05.2023
IMDRF meeting in Brussels
Posted on 06.04.2023
IMDRF Management Committee meeting in Brussels, March 2023
Posted on 02.03.2023